XML 39 R24.htm IDEA: XBRL DOCUMENT v3.22.2
LOSS PER SHARE
 6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
LOSS PER SHARE LOSS PER SHARE
Net loss per share attributable to Bausch Health Companies Inc. were calculated as follows:
Three Months Ended
June 30,		Six Months Ended
June 30,
(in millions, except per share amounts)2022202120222021
Net loss attributable to Bausch Health Companies Inc.$(145)$(595)$(214)$(1,205)
Basic and diluted weighted-average common shares outstanding362.2 359.1 361.5 358.0 
Basic and diluted loss per share attributable to Bausch Health
Companies Inc.
$(0.40)$(1.66)$(0.59)$(3.37)
During the three and six months ended June 30, 2022 and 2021, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approximately 1,184,000 and 4,558,000 common shares for the three months ended June 30, 2022 and 2021, respectively, and approximately 2,392,000 and 5,608,000 common shares for the six months ended June 30, 2022 and 2021, respectively.
During the three and six months ended June 30, 2022, time-based RSUs, performance-based RSUs and stock options to purchase approximately 15,372,000 and 13,771,000 common shares, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method. During the three and six months ended June 30, 2021, time-based RSUs, performance-based RSUs and stock options to purchase approximately 3,929,000 and 4,110,000 common shares, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method. During the three months ended June 30, 2022, an additional 156,000 performance-based RSUs were not included in the computation of diluted earnings per share as the required performance conditions had not been met.